• Explore /
  • Poster
  • / Subgroup-level network meta-analysis for efficacy of first-line immunotherapy-based treatments in advanced non-small cell lung cancer.

Subgroup-level network meta-analysis for efficacy of first-line immunotherapy-based treatments in advanced non-small cell lung cancer.

Abstract Poster

Authors

null

Fang Wu

Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China

Fang Wu , Wentao Tian , Chenghui Cao , Jiawen Ke , Nuopei Tan , Yuwen Cai , Yue Zeng , Yue Pan , Xiaohan Liu , Lishu Zhao , Long Shu , Junqi Liu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 9064)

DOI

10.1200/JCO.2021.39.15_suppl.9064

Abstract #

9064

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.

Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.

First Author: Laurent Mhanna

First Author: Ahmad A. Tarhini

First Author: Kohei Shitara

First Author: Antoine Italiano